Your browser doesn't support javascript.
loading
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue.
Loria, Rossella; Vici, Patrizia; Di Lisa, Francesca Sofia; Soddu, Silvia; Maugeri-Saccà, Marcello; Bon, Giulia.
Afiliação
  • Loria R; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Vici P; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Lisa FS; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Soddu S; Medical Oncology A, Department of Radiological, Oncological, and Anatomo-Pathological Sciences, Umberto I University Hospital, University Sapienza, Rome, Italy.
  • Maugeri-Saccà M; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Bon G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Front Oncol ; 12: 1063651, 2022.
Article em En | MEDLINE | ID: mdl-36387137
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2022.877380.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article